1
|
Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage.
|
Breast Cancer Res Treat
|
2004
|
1.78
|
2
|
Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments.
|
Nucl Med Biol
|
2005
|
1.28
|
3
|
Surgical management of early stage invasive breast cancer: a practice guideline.
|
Can J Surg
|
2005
|
1.12
|
4
|
Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series.
|
Breast Cancer Res Treat
|
2008
|
1.08
|
5
|
IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways.
|
Breast Cancer Res Treat
|
2011
|
1.00
|
6
|
Changes in psychosocial functioning 1 year after mastectomy alone, delayed breast reconstruction, or immediate breast reconstruction.
|
Ann Surg Oncol
|
2011
|
0.98
|
7
|
Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments.
|
Nucl Med Commun
|
2005
|
0.96
|
8
|
Willingness of breast cancer survivors to participate in a randomized controlled trial of digital mammography with or without MRI as breast cancer surveillance: a feasibility study.
|
Breast
|
2010
|
0.78
|
9
|
Intraoperative consultation for axillary sentinel lymph node biopsy: an 8-year audit.
|
Int J Surg Pathol
|
2009
|
0.77
|
10
|
Sensitivity of BRCA-1-related breast cancer to neoadjuvant chemotherapy: practical implications.
|
Breast J
|
2003
|
0.77
|
11
|
A human bone NOD/SCID mouse model to distinguish metastatic potential in primary breast cancers.
|
Cancer Biol Ther
|
2009
|
0.77
|
12
|
A prospective study of mastectomy patients with and without delayed breast reconstruction: long-term psychosocial functioning in the breast cancer survivorship period.
|
J Surg Oncol
|
2014
|
0.77
|
13
|
The role of cytokeratin 5/6 as an adjunct diagnostic tool in breast core needle biopsies.
|
Int J Surg Pathol
|
2008
|
0.76
|
14
|
A positive contrast, tri-modality tissue marker for breast tumour localization.
|
Phys Med Biol
|
2007
|
0.75
|
15
|
Development of an MRI/x-ray/ultrasound compatible marker for pre-operative breast tumour localization.
|
Phys Med Biol
|
2005
|
0.75
|
16
|
Why Some Mastectomy Patients Opt to Undergo Delayed Breast Reconstruction: Results of a Long-Term Prospective Study.
|
Plast Reconstr Surg
|
2017
|
0.75
|